Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev LtdfiledCriticalGlaxosmithkline Ip Dev Ltd
Priority claimed from PCT/IB2014/059004external-prioritypatent/WO2014125444A1/fr
Publication of MA38326A1publicationCriticalpatent/MA38326A1/fr
Publication of MA38326B1publicationCriticalpatent/MA38326B1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
L'invention concerne des composés de formule (i) dans laquelle x, y, z1, z2, z3, z4, r5, ra, m, a. L, et b ont la signification indiquée dans la description, ainsi que des procédés de fabrication et d'utilisation de ceux-ci.
MA38326A2013-02-152014-02-14Amides hétérocycliques à utiliser en tant qu'inhibiteurs de kinase
MA38326B1
(fr)